INT192652

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.32
First Reported 2005
Last Reported 2006
Negated 0
Speculated 0
Reported most in Body
Documents 2
Total Number 2
Disease Relevance 1.30
Pain Relevance 0.18

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

plasma membrane (Capns1) cytoplasm (Capns1)
Anatomy Link Frequency
erythrocyte 1
arm 1
Capns1 (Rattus norvegicus)
Pain Link Frequency Relevance Heat
corticosteroid 38 92.04 High High
Infliximab 1 70.80 Quite High
Etanercept 1 70.20 Quite High
antagonist 8 50.00 Quite Low
withdrawal 3 36.72 Quite Low
cytokine 2 33.88 Quite Low
Inflammation 13 5.00 Very Low Very Low Very Low
Pain 5 5.00 Very Low Very Low Very Low
Acupuncture 3 5.00 Very Low Very Low Very Low
Pain scale 3 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Syndrome 189 100.00 Very High Very High Very High
Recurrence 10 99.28 Very High Very High Very High
Disease 24 84.16 Quite High
Vasculitis 3 68.64 Quite High
Chronic Sinusitis 31 64.52 Quite High
Nicotine Addiction 1 54.40 Quite High
Pressure And Volume Under Development 10 49.00 Quite Low
Sinusitis 18 32.40 Quite Low
Eosinophilia 11 22.52 Low Low
Increased Venous Pressure Under Development 23 18.60 Low Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Because patients in one of the treatment arms were given antibiotics and other medication as part of the protocol, we excluded patients in this treatment arm from the analysis of responsiveness of the CSS Medication usage and Total scales.
Regulation (responsiveness) of CSS in arm
1) Confidence 0.32 Published 2006 Journal BMC Ear Nose Throat Disord Section Body Doc Link PMC1468424 Disease Relevance 0.12 Pain Relevance 0
Monitoring the responsiveness of CSS to treatment and recurrence/relapse of CSS is best achieved by following the eosinophil count and erythrocyte sedimentation rate.
Regulation (responsiveness) of CSS in erythrocyte associated with syndrome and recurrence
2) Confidence 0.00 Published 2005 Journal Therapeutics and Clinical Risk Management Section Body Doc Link PMC1661620 Disease Relevance 1.18 Pain Relevance 0.18

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox